Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study.
Nutrients. 2021 Nov 28;13(12):4295. doi: 10.3390/nu13124295.
Nutrients. 2021.
PMID: 34959847
Free PMC article.
Clinical Trial.
Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified citrus pectin (PectaSol(), P-MCP), a dietary polysaccharide, is an established antagonist of galectin-3, a carbohydrate-binding protein …
Optimal therapy of biochemically relapsed prostate cancer (BRPC) after local treatment is elusive. An established modified citrus …